Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	96.66	-10.67	-319.43
Graham Fair Price	28.02	0.33	0.26
PEG	-69.10	-0.01	0.04
Price/Book	-19.66	0.08	0.10
Price/Cash Flow	65.55	-4.01	-11.64
Prices/Earnings	59.83	-1.04	-2.59
Price/Sales	-60.32	5.36	13.52
Price/FCF	65.55	-4.01	-11.64
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-44.26	0.56	1.00
Operating Margin	-26.35	-1.60	-1.27
ROA	-100.00	-0.02	< 0.005
ROE	< 0.005	-0.02	-100.00
ROIC	< 0.005	-0.02	-134.86
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	3.95	-0.81	391.22
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.69	-1.56	127.46
EPS QOQ	0.62	-0.81	30.00
FCF QOQ	0.65	-1.33	103.63
Revenue QOQ	-0.49	1.02	109.09
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	85.18	100.00
Days Sales Outstanding (DSO)	0.00	46.52	100.00
Inventory Turnover	0.00	1.06	100.00
Debt/Capitalization	0.03	0.14	341.01
Quick Ratio	3.21	0.27	-91.69
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	0.55	0.50	-9.48
Cash	0.02	0.02	-9.48
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	< 0.005	-111.09
Revenue	< 0.005	< 0.005	83.29
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	3.21	0.31	-90.48
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	20.10	-6.42	-68.07
Naive Interpretation	Member

06 - Financial Health · Bad

Rating